NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne 医疗公司的股票在公司报告了2024财年年度业绩同比增长，并发布了2025财年产品营业收入指导预期同比增长后，交易价格上涨。
NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.
NeuroOne 医疗公司的股票在公司报告了2024财年年度业绩同比增长，并发布了2025财年产品营业收入指导预期同比增长后，交易价格上涨。
热门讨论
中美谈话新契机，通胀不再？
🎙️讨论： 1. 你认为特朗普上台后，对华政策将如何影响中国资产？ 2. 美股市场通胀风险下降，有哪些利好板块？
Moomoo News Global
2024/12/09 20:23
中国将在未来一年采取"适度宽松"的货币政策，这是自2011年以来的首次转向宽松。